Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
Condition(s):Cystic FibrosisLast Updated:November 27, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:November 27, 2018Completed
Condition(s):Hospital Acquired Pneumonia; Ventilator Acquired Pneumonia; Complicated Intra Abdominal InfectionsLast Updated:November 3, 2023Recruiting
Condition(s):Pharmacokinetics of Avycaz in ICU PatientsLast Updated:March 6, 2019Completed
Condition(s):Carbapenem-Resistant Enterobacteriaceae InfectionLast Updated:July 20, 2021Completed
Condition(s):Hospitalized Children With Suspected or Confirmed Nosocomial PneumoniaLast Updated:September 9, 2022Terminated
Condition(s):Renal Failure; Bacterial Infections; Critical IllnessLast Updated:April 10, 2019Unknown status
Condition(s):Severe SepsisLast Updated:August 1, 2023Recruiting
Condition(s):Carbapenem-Resistant Enterobacteriaceae InfectionLast Updated:June 24, 2022Recruiting
Condition(s):Gram-negative Bacterial InfectionLast Updated:March 26, 2024Terminated
Condition(s):Augmented Renal Clearance (ARC); Systemic Inflammatory Response Syndrome (SIRS)Last Updated:April 7, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.